Treatment of Patients with Recently Exacerbated Schizophrenia with Paliperidone Palmitate: A Pilot Study of Efficacy and Tolerability

BACKGROUND: Paliperidone palmitate is a long-acting, second-generation antipsychotic (SGA) indicated for the treatment of acute exacerbations and maintenance treatment of adults with schizophrenia. This study addressed the response to paliperidone palmitate in Latin American patients with acute symp...

Descripción completa

Detalles Bibliográficos
Autores principales: Gattaz, Wagner F, Saracco-Alvarez, Ricardo, Daltio, Claudiane Salles, Van de Bilt, Martinus T, Ortegón, Jose Julian, Villaseñor-Bayardo, Sergio J, Louzã, Mario, Elkis, Helio, Soares, Bernardo, Cabrera Jaramillo, Patricia, Lawson, Fabio, Díaz-Galvis, Leonardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490440/
https://www.ncbi.nlm.nih.gov/pubmed/32982245
http://dx.doi.org/10.2147/NDT.S233537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490440/
https://www.ncbi.nlm.nih.gov/pubmed/32982245
http://dx.doi.org/10.2147/NDT.S233537

Ejemplares similares